Skip to main content
Erschienen in: Rheumatology International 9/2008

01.07.2008 | Original Article

Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population

verfasst von: H. J. Lee, G. H. Lee, S. Nah, K. H. Lee, H. Yang, Y. M. Kim, W. Chun, S. Hong, S. Kim

Erschienen in: Rheumatology International | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Due to an imbalance in the MMP:TIMP ratio determined a tissue damage in arthritis, it is hypothesized that polymorphic variations of the TIMP genes are associated with regulation of the MMP:TIMP balance. To test this hypothesis, the presence of single nucleotide polymorphisms (SNPs) located in the human TIMP-2 and TIMP-4 genes was confirmed in the Korean RA and OA patients. We performed a case-control study comprising 109 unrelated Korean OA patients, 177 unrelated Korean RA patients and 175 healthy subjects. There were statistically significant differences in the genotype distribution and allele frequencies of the C/T polymorphism of TIMP-4 gene between OA and control groups (P = 0.0002 and P = 0.001, respectively). However, no significant association between TIMP-2 polymorphisms and OA was observed. Also, no difference was observed when allele or genotype frequencies of both TIMP-2 and TIMP-4 gene polymorphisms were compared between RA and controls. We demonstrated that the C/T polymorphism which is located on the 3′-untranslational regions of the TIMP-4 gene might be associated with susceptibility to OA patients.
Literatur
1.
Zurück zum Zitat Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA, Blair SN, Berman BM, Fries JF, Weinberger M, Lorig KR, Jacobs JJ, Goldberg V (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646PubMed Felson DT, Lawrence RC, Hochberg MC, McAlindon T, Dieppe PA, Minor MA, Blair SN, Berman BM, Fries JF, Weinberger M, Lorig KR, Jacobs JJ, Goldberg V (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646PubMed
3.
Zurück zum Zitat Sowers M (2001) Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 13:447–451PubMedCrossRef Sowers M (2001) Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 13:447–451PubMedCrossRef
4.
Zurück zum Zitat Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D (1996) Genetic influences on osteoarthritis in women: a twin study. BMJ 312:940–943PubMed Spector TD, Cicuttini F, Baker J, Loughlin J, Hart D (1996) Genetic influences on osteoarthritis in women: a twin study. BMJ 312:940–943PubMed
6.
Zurück zum Zitat Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocyte of human osteoarthritic cartilage: association with degenerative changes. Arthritis Rheum 44:585–594PubMedCrossRef Tetlow LC, Adlam DJ, Woolley DE (2001) Matrix metalloproteinase and proinflammatory cytokine production by chondrocyte of human osteoarthritic cartilage: association with degenerative changes. Arthritis Rheum 44:585–594PubMedCrossRef
7.
Zurück zum Zitat Solovieva S, Hirvonen A, Siivola P, Vehmas T, Luoma K, Riihimaki H, Leino-Arjas P (2006) Vitamin D receptor gene polymorphisms and susceptibility of hand osteoarthritis in Finnis women. Arthritis Res Ther 8:R20PubMedCrossRef Solovieva S, Hirvonen A, Siivola P, Vehmas T, Luoma K, Riihimaki H, Leino-Arjas P (2006) Vitamin D receptor gene polymorphisms and susceptibility of hand osteoarthritis in Finnis women. Arthritis Res Ther 8:R20PubMedCrossRef
8.
Zurück zum Zitat Mustafa Z, Chapman K, Irven C, Carr AJ, Clipsham K, Chitnavis J, Sinsheimer JS, Bloomfield VA, McCartney M, Cox O, Sykes B, Loughlin J (2000) Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis. Rheumatology 39:299–306PubMedCrossRef Mustafa Z, Chapman K, Irven C, Carr AJ, Clipsham K, Chitnavis J, Sinsheimer JS, Bloomfield VA, McCartney M, Cox O, Sykes B, Loughlin J (2000) Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis. Rheumatology 39:299–306PubMedCrossRef
9.
Zurück zum Zitat Loughlin J, Sinsheimer JS, Mustafa Z, Carr AJ, Clipsham K, Bloomfield VA, Chitnavis J, Bailey A, Sykes B, Chapman K (2000) Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis. J Rheumatol 27:779–784PubMed Loughlin J, Sinsheimer JS, Mustafa Z, Carr AJ, Clipsham K, Bloomfield VA, Chitnavis J, Bailey A, Sykes B, Chapman K (2000) Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis. J Rheumatol 27:779–784PubMed
10.
Zurück zum Zitat Cawston T (1998) Matrix metalloproteinases and TIMPs: proterties and implications for the rheumatic diseases. Mol Med Today 3:130–137CrossRef Cawston T (1998) Matrix metalloproteinases and TIMPs: proterties and implications for the rheumatic diseases. Mol Med Today 3:130–137CrossRef
11.
Zurück zum Zitat Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283PubMed
12.
Zurück zum Zitat Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378PubMed Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374–17378PubMed
13.
Zurück zum Zitat Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP4). J Biol Chem 272:20479–20483PubMedCrossRef Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE (1997) Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP4). J Biol Chem 272:20479–20483PubMedCrossRef
14.
Zurück zum Zitat Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61:3610–3618PubMed Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61:3610–3618PubMed
15.
Zurück zum Zitat Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678–685PubMedCrossRef Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF Jr. (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678–685PubMedCrossRef
16.
Zurück zum Zitat Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matriz metalloproteinase and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455–461PubMedCrossRef Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y (2000) Matriz metalloproteinase and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59:455–461PubMedCrossRef
17.
Zurück zum Zitat Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol 33:1523–1529PubMed Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. J Rheumatol 33:1523–1529PubMed
18.
Zurück zum Zitat Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J (1994) Serum metalloproteinase and their inhibitors: markers for malignant potential. Br J Cancer 70:506–512PubMed Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J (1994) Serum metalloproteinase and their inhibitors: markers for malignant potential. Br J Cancer 70:506–512PubMed
19.
Zurück zum Zitat Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2002) Serum metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid arthritis. Rheumatology (Oxford) 41:78–87CrossRef Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J (2002) Serum metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid arthritis. Rheumatology (Oxford) 41:78–87CrossRef
20.
Zurück zum Zitat Huang W, Li WQ, Dehnade F, Zafarullah M (2002) Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85:295–303PubMedCrossRef Huang W, Li WQ, Dehnade F, Zafarullah M (2002) Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85:295–303PubMedCrossRef
21.
Zurück zum Zitat Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMed Lee YH, Kim HJ, Rho YH, Choi SJ, Ji JD, Song GG (2003) Functional polymorphisms in matix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis. Scand J Rheumatol 32:235–239PubMed
22.
Zurück zum Zitat Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 4:147–149CrossRef Mattey DL, Nixon NB, Dawes PT, Ollier WE, Hajeer AH (2004) Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 4:147–149CrossRef
23.
Zurück zum Zitat Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G (2004) Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 6:R199–R207PubMedCrossRef Dorr S, Lechtenbohmer N, Rau R, Herborn G, Wagner U, Muller-Myhsok B, Hansmann I, Keyszer G (2004) Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritis. Arthritis Res Ther 6:R199–R207PubMedCrossRef
24.
Zurück zum Zitat Zhao J, Hyman L, Moore C (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrlationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63:405–445PubMed Zhao J, Hyman L, Moore C (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation, and interrlationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63:405–445PubMed
25.
Zurück zum Zitat Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 120:1–21PubMedCrossRef Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet 120:1–21PubMedCrossRef
26.
Zurück zum Zitat Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120:301–333PubMedCrossRef Chen J, Ferec C, Cooper DN (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120:301–333PubMedCrossRef
27.
Zurück zum Zitat Clements DN, Carter SD, Innes JF, Ollier WER, Day PJR (2006) Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction. Arthritis Res Ther 8:1–9CrossRef Clements DN, Carter SD, Innes JF, Ollier WER, Day PJR (2006) Analysis of normal and osteoarthritic canine cartilage mRNA expression by quantitative polymerase chain reaction. Arthritis Res Ther 8:1–9CrossRef
28.
Zurück zum Zitat Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SM, Edwards DR, Parker AE, Clark IM (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131–141PubMedCrossRef Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, Brockbank SM, Edwards DR, Parker AE, Clark IM (2004) Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 50:131–141PubMedCrossRef
29.
Zurück zum Zitat Celiker MY, Ramamurthy N, Xu JW, Wang M, Jiang Y, Greenwald R, Shi YE (2002) Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery. Arthritis Rheum 46:3361–3368PubMedCrossRef Celiker MY, Ramamurthy N, Xu JW, Wang M, Jiang Y, Greenwald R, Shi YE (2002) Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinases 4 gene delivery. Arthritis Rheum 46:3361–3368PubMedCrossRef
Metadaten
Titel
Association of TIMP-4 gene polymorphism with the risk of osteoarthritis in the Korean population
verfasst von
H. J. Lee
G. H. Lee
S. Nah
K. H. Lee
H. Yang
Y. M. Kim
W. Chun
S. Hong
S. Kim
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 9/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0545-4

Weitere Artikel der Ausgabe 9/2008

Rheumatology International 9/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.